Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension

I. Barroso, M. Gurnell, V. E. F. Crowley, M. Agostini, J. W. Schwabe, M. A. Soos, G. Li Maslen, T. D. M. Williams, H. Lewis, A. J. Schafer, V. K. K. Chatterjee () and S. O'Rahilly ()
Additional contact information
I. Barroso: Incyte Europe Ltd
M. Gurnell: Departments of Medicine
V. E. F. Crowley: Departments of Medicine
M. Agostini: Departments of Medicine
J. W. Schwabe: Medical Research Council, Laboratory of Molecular Biology
M. A. Soos: Departments of Medicine
G. Li Maslen: Incyte Europe Ltd
T. D. M. Williams: Prince Philip Hospital
H. Lewis: Selly Oak Hospital
A. J. Schafer: Incyte Europe Ltd
V. K. K. Chatterjee: Departments of Medicine
S. O'Rahilly: Departments of Medicine

Nature, 1999, vol. 402, issue 6764, 880-883

Abstract: Abstract Thiazolidinediones are a new class of antidiabetic agent that improve insulin sensitivity and reduce plasma glucose and blood pressure in subjects with type 2 diabetes1. Although these agents can bind and activate an orphan nuclear receptor, peroxisome proliferator-activated receptor gamma (PPARγ), there is no direct evidence to conclusively implicate this receptor in the regulation of mammalian glucose homeostasis2. Here we report two different heterozygous mutations in the ligand-binding domain of PPARγ in three subjects with severe insulin resistance. In the PPARγ crystal structure, the mutations destabilize helix 12 which mediates transactivation. Consistent with this, both receptor mutants are markedly transcriptionally impaired and, moreover, are able to inhibit the action of coexpressed wild-type PPARγ in a dominant negative manner. In addition to insulin resistance, all three subjects developed type 2 diabetes mellitus and hypertension at an unusually early age. Our findings represent the first germline loss-of-function mutations in PPARγ and provide compelling genetic evidence that this receptor is important in the control of insulin sensitivity, glucose homeostasis and blood pressure in man.

Date: 1999
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/47254 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:402:y:1999:i:6764:d:10.1038_47254

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/47254

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().